OVID - Bullish Momentum. Pullback Possible First

Ovid Therapeutics, Inc. focuses on developing medicines for patients and families living with rare neurological disorders. The company was founded by Matthew During in April 2014 and is headquartered in New York, NY.

SHORT INTEREST
426.41K 08/15/19

P/E Current
-1.03

P/E Ratio (with extraordinary items)
-1.59

Average Recommendation: BUY Average Target Price: 12.00